Will screening colonoscopy disappear and transform gastroenterology practice? Threats to clinical practice and recommendations to reduce their impact: Report of a consensus conference conducted by the AGA Institute Future Trends Committee
ABSTRACT The AGA Institute Future Trends Committee (FTC) developed this report based on a consensus conference it convened on April 1-2, 2006, in Washington, DC. The report was prepared for the FTC by Carol Regueiro, MD, a medical writer under contract to the AGA Institute, and Michael Stolar, PhD, staff liaison to the FTC. It was approved by the FTC on July 12, 2006, and accepted by the AGA Institute Governing Board on July 22, 2006. This report reflects the panel's assessment of information available at the time of the conference. Readers should view this report in the context of data that will continue to accumulate and facts that may change after its creation.
- SourceAvailable from: capitol.hawaii.gov
- Acta Endoscopica 10/2006; 36(5):786-788. DOI:10.1007/BF03018530 · 0.16 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Endoscopic retrograde cholangiopancreatography (ERCP), once a popular modality for diagnosing biliary tract and pancreatic disease, has passed its peak utilization. In the current issue of AJG, Jamal and colleagues summarize the trends in ERCP utilization in the United States from 1988 to 2002. While ERCP utilization had increased among certain ethnic groups, its overall use has dropped considerably since 1996. In particular, they report that the use of ERCP as a diagnostic tool and in the outpatient setting has declined. The introduction of less invasive pancreaticobiliary imaging tools, namely, endoscopic ultrasound (EUS) and magnetic resonance cholangiopancreatography (MRCP), is likely responsible for this trend. However, ERCP is still used widely and appropriately in the therapy of pancreaticobiliary disorders. The complementary nature of alternative diagnostic tools such as EUS suggests that ERCP use will continue at its current rate, rather than fall out of favor.The American Journal of Gastroenterology 06/2007; 102(5):976-7. DOI:10.1111/j.1572-0241.2007.01121.x · 9.21 Impact Factor